Exercise Prehabilitation for Patients With NSCLC Before Surgery

Sponsor
Tongji Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05608759
Collaborator
(none)
30
1
1
13.5
2.2

Study Details

Study Description

Brief Summary

To explore the safety and compliance of a wearable telemedicine device that can receive basic vital signs in real time, and its active supervision mode with real-time adjustment of exercise prescription for preoperative prehabilitation exercises in patients at home; and to evaluate the effectiveness of preoperative prehabilitation exercises in a telemedicine active supervision mode in patients undergoing thoracoscopic lung tumour resection, taking into account the patient's cardiopulmonary exercise test, postoperative complications and quality of life scores.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Multimodal prehabilitation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effect of a Home-based, Supervised Prehabilitation With Wearable Technology for Patients With Non-small Cell Lung Cancer Before Lung Resection: a Prospective Pilot Study
Actual Study Start Date :
Jun 16, 2022
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: single arm

4 weeks of multimodal pre-rehabilitation

Behavioral: Multimodal prehabilitation
4 weeks of an supervised, pre-operative exercise prescription augmented by a wearable fitness device.

Outcome Measures

Primary Outcome Measures

  1. Exercise capacity [Baseline, 4 weeks after prehabilitation exercise]

    Exercise testing on a cycloergometer(VO2 max)

Secondary Outcome Measures

  1. Forced expiratory volume in 1 s(FEV1) [Baseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgery]

    Forced expiratory volume in 1 s (FEV1) of pulmonary function will be measured in liters

  2. Forced vital capacity (FVC) [Baseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgery]

    Forced vital capacity (FVC) of pulmonary function will be measured in liters.

  3. Acceptance of technology [4 weeks of prehabilitation exercise]

    number of hours the fitness tracker was worn in pre-operative period

  4. Change in quality of life [Baseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgery]

    as assessed by the EORTC QLQ C30 questionnaire

  5. Change in grip-strength [Baseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgery]

    Grip strength per dynamometer

  6. Length of stay in hospital [Up to 30 postoperative days]

    Number of days from surgery to discharge home

  7. Post-operative complications [From day of surgery to 30-days afterwards]

    Classified using the Clavien Dindo Classification

  8. Adherence to exercise [4 weeks of prehabilitation exercise]

    number of completed pre-operative exercise sessions divided by number of prescribed sessions, according to exercise log

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Capacity to give informed consent.

  2. Are able to tolerate surgery (i.e., segmentectomy, lobectomy) as indicated by standard clinical pre-op evaluation, including pulmonary function tests and cardiopulmonary exercise testing.

  3. Patients who can use a smartphone application.

  4. Patients who are diagnosed of stage I or II Non-small-cell lung carcinoma (NSCLC) diagnosis, with or without pre-operative histologic confirmation.

  5. Patients who can perform an exercise program for at least 4 weeks from the first visit to the preoperative clinic to elective surgery.

Exclusion Criteria:
  1. Known contraindication for cardiopulmonary exercise testing.

  2. Patients who have a major medical or psychiatric disorder that is expected to affect exercise.

  3. Pregnancy or lactating women.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tongji Hospital Wuhan Hubei China 430030

Sponsors and Collaborators

  • Tongji Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zhang Ni, Professor, Tongji Hospital
ClinicalTrials.gov Identifier:
NCT05608759
Other Study ID Numbers:
  • TJ-IRB20220564
First Posted:
Nov 8, 2022
Last Update Posted:
Nov 8, 2022
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zhang Ni, Professor, Tongji Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 8, 2022